Search - tctmd.com

Displaying 301 - 320 of 926

Sort: Relevancy | Date

News Conference News

Wrong BP Cuff Size May Lead to Wildly Inaccurate Readings

L.A. McKeown

March 02, 2022

News Daily News

Better 15-Year Survival With Ross Procedure Than Bioprosthetic AVR

Caitlin E. Cox

February 22, 2022

News Daily News

Absence of CAC May be Protective Even in Patients With Very High Cholesterol

Michael O'Riordan

February 14, 2022

News Daily News

Chinese Herbal Formula Matches Losartan in Patients With Mild Hypertension

Caitlin E. Cox

February 11, 2022

News Daily News

Acetaminophen Raises BP, Just Like NSAIDs Do, in Patients With Hypertension

Yael L. Maxwell

February 09, 2022

News Conference News THT 2022

Probe Beyond Ejection Fraction to Understand and Manage HFpEF

L.A. McKeown

February 07, 2022

News Conference News THT 2022

LAVA ECMO: Early Data Point to Hemodynamic Benefits, Safety

Caitlin E. Cox

February 02, 2022

News Daily News

Hearts, Lungs, Kidneys: Mild-to-Moderate COVID-19 Leaves a Mark

Caitlin E. Cox

January 14, 2022

News Daily News

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

Caitlin E. Cox

December 28, 2021

News Daily News

Discharge Safe as Early as a Day After Primary PCI for STEMI

L.A. McKeown

December 15, 2021

News Daily News

Extended DANISH Follow-up Supports ICD Benefits in Younger Nonischemic HF Patients

Todd Neale

December 14, 2021

News Daily News

New Revascularization Guidelines Plug Radial Access, Staged PCI, and Shorter DAPT

Michael O'Riordan

December 09, 2021

News Conference News PCR London Valves 2021

Good Results but Small Numbers With JenaValve Trilogy in Severe AR

Michael O'Riordan

November 26, 2021

News Conference News AHA 2021

Risk-Based EHR Alert Doesn’t Improve HF Care or Outcomes: REVEAL-HF

Michael O'Riordan

November 19, 2021

News Conference News AHA 2021

Pandemic Blamed for Loss of BP Control That Has Not Fully Rebounded

L.A. McKeown

November 18, 2021

News Conference News AHA 2021

Pharmacist-Led Intervention Slashes LDL and BP in 10,000 Patients

Michael O'Riordan

November 13, 2021

Presentation TCT 2021

Cardiac Neuromodulation Therapy Effect on Systolic Blood Pressure and Pulse Pressure in Patients with Isolated Systolic Hypertension In A Randomized Double-Blind Study Together With Long Term Follow Up Results (Backbeat Medical)

Presenter: Daniel Burkhoff

November 05, 2021

Presentation TCT 2021

Cardiac Neuromodulation Therapy reduces Systolic Blood Pressure and Pulse Pressure in Patients With Isolated Systolic Hypertension in a Randomized Double-Blind Study

Presenter: Daniel Burkhoff

November 04, 2021

News Conference News TCT 2021

Renal Denervation May Help Cut BP Meds, Sham-Controlled Trial Hints

Todd Neale

November 04, 2021

News Daily News

Tendyne at 2 Years: Confirmed Feasibility but High Mortality With TMVR

Yael L. Maxwell

November 03, 2021

Advertisement

Wrong BP Cuff Size May Lead to Wildly Inaccurate Readings

Better 15-Year Survival With Ross Procedure Than Bioprosthetic AVR

Absence of CAC May be Protective Even in Patients With Very High Cholesterol

Chinese Herbal Formula Matches Losartan in Patients With Mild Hypertension

Acetaminophen Raises BP, Just Like NSAIDs Do, in Patients With Hypertension

Probe Beyond Ejection Fraction to Understand and Manage HFpEF

LAVA ECMO: Early Data Point to Hemodynamic Benefits, Safety

Hearts, Lungs, Kidneys: Mild-to-Moderate COVID-19 Leaves a Mark

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

Discharge Safe as Early as a Day After Primary PCI for STEMI

Extended DANISH Follow-up Supports ICD Benefits in Younger Nonischemic HF Patients

New Revascularization Guidelines Plug Radial Access, Staged PCI, and Shorter DAPT

Good Results but Small Numbers With JenaValve Trilogy in Severe AR

Risk-Based EHR Alert Doesn’t Improve HF Care or Outcomes: REVEAL-HF

Pandemic Blamed for Loss of BP Control That Has Not Fully Rebounded

Pharmacist-Led Intervention Slashes LDL and BP in 10,000 Patients

Cardiac Neuromodulation Therapy Effect on Systolic Blood Pressure and Pulse Pressure in Patients with Isolated Systolic Hypertension In A Randomized Double-Blind Study Together With Long Term Follow Up Results (Backbeat Medical)

Cardiac Neuromodulation Therapy reduces Systolic Blood Pressure and Pulse Pressure in Patients With Isolated Systolic Hypertension in a Randomized Double-Blind Study

Renal Denervation May Help Cut BP Meds, Sham-Controlled Trial Hints

Tendyne at 2 Years: Confirmed Feasibility but High Mortality With TMVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content